Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Phio Pharmaceuticals Corp
PHIO
Healthcare
Biotechnology
Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company. The Company's INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. It is developing therapeutics that are designed to leverage INTASYL to target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or...
drug delivery systems. The Company's pipeline is focused on the treatment of cutaneous Squamous Cell Carcinoma (cSCC) and melanoma. Its product pipeline includes PH-762 and PH-894. PH-762 is an INTASYL compound designed to reduce the expression of cell death protein 1 (PD-1). PD-1 is a protein that inhibits T cells’ ability to kill cancer cells and is a clinically validated target in immunotherapy. PH-894 is an INTASYL compound that is designed to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, thereby affecting the immune system as well as the tumor.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:PHIO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
Next
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Nov 03, 2025 9:21am
Buy buddy buy.
Otherwise it will be FOMO time for you fellas out there today anyway
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 25, 2025 3:46pm
PHIO....And u thought u were going to be rich...nope
Welcome to all the New Bagholders!!!! Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds 2025-07-25 12:05 ET - News Release
...more
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 1:20pm
PHIO....N.H.O.D posted 5 mins ago $3.19
No position On watch....vols aren't good enough
(476)
•••
Iseneschal
X
Comment by
Iseneschal
on Jun 06, 2025 10:16am
RE:Buy buddy buy because it's taking off this morning.
Possibly....vols aren't too bad this a.m (640K) and the sh price is up 42 cents I'd like to see this bust thru the $3.00 with volume....until then I'm going to call this an "Also
...more
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jun 05, 2025 9:22am
Buy buddy buy because it's taking off this morning.
This stock is signalling a big upswing for it today
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 03, 2025 7:46am
New Press Release - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Registration Link for Presentation and live Q&A to take place, Tuesday February 4, 2025 at 2:00 pm ESTMarlborough, Massachusetts--(Newsfile Corp. - February 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL®...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 22, 2025 7:02am
New Press Release - Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Registration Link for Presentation and live Q&A to take place, Wednesday January 29, 2025 at 2:00 pm ESTMarlborough, Massachusetts--(Newsfile Corp. - January 22, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 21, 2025 4:16pm
New Press Release - Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Raised approximately $12.08 million in gross proceeds since beginning of December 2024 Proceeds intended to be directed for development costs to be incurred in connection with PH-762 clinical activitiesMarlborough, Massachusetts--(Newsfile Corp. - January 21, 2025) - Phio Pharmaceuticals Corp...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 16, 2025 1:01pm
New Press Release - Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Marlborough, Massachusetts--(Newsfile Corp. - January 16, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells,...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 15, 2025 7:01am
New Press Release - Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Marlborough, Massachusetts--(Newsfile Corp. - January 15, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells,...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 14, 2025 7:01am
New Press Release - Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Marlborough, Massachusetts--(Newsfile Corp. - January 14, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells,...
read article.
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 13, 2025 1:20pm
Sold out of this stock today.Wow.
It was time for me to take my profits out of this one . It was a good time for me to cash out of it after holding this stock for about a month.Well,the stock price per share was a quadruple for me
...more
(61)
•••
Consvestor
X
Comment by
Consvestor
on Jan 13, 2025 10:48am
RE:Phio Pharmaceuticals Announces Promising Results of Second C
Wow! $14 million market cap for a company that possibly appears to have cured a very common type of cancer? This could be huge. Certainly worth throwing a few dollars into this.
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 13, 2025 10:16am
PHIO....Scalp #2
huge ; )
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 13, 2025 8:52am
PHIO....ripping on NR
Scalped
Prev
1
2
3
4
5
6
7
8
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods